Retour sur lavenir.net
   ARGENX SE 757.800 € (-0,24 %)     MONTEA 66.200 € (-1,05 %)     AZELIS GROUP 10.890 € (+4,61 %)     VGP 79.700 € (-1,85 %)     AGEAS 70.650 € (-0,42 %)     AB INBEV 68.840 € (-1,15 %)     UMICORE 20.460 € (+0,10 %)     KBC 118.950 € (-1,33 %)     GIMV 45.250 € (-0,55 %)     COLRUYT 37.420 € (+0,65 %)     TITAN S.A. 50.050 € (-0,30 %)     OXURION 0.003 € (-7,14 %)     D'IETEREN GROUP 169.200 € (-1,28 %)     WDP 21.540 € (-1,19 %)     LOTUS BAKERIES 10 900.000 € (-0,91 %)     SOLVAY 27.000 € (+2,20 %)     SYENSQO 67.800 € (+0,37 %)     XIOR 27.400 € (-1,08 %)     SOFINA 225.200 € (-1,05 %)     UCB 233.100 € (-1,06 %)     AEDIFICA 68.250 € (-0,87 %)     VASTNED 29.950 € (+0,34 %)     CAMPINE 212.000 € (+0,47 %)     ACKERMANS V.HAAREN 265.400 € (-0,82 %)     KBC ANCORA 83.300 € (-1,54 %)     CARE PROPERTY INV. 12.540 € (-0,63 %)     BPOST 1.586 € (-1,49 %)     FAGRON 23.800 € (-0,83 %)     BARCO 8.350 € (+0,12 %)     ELIA GROUP 137.900 € (-0,58 %)     ONWARD MEDICAL 2.480 € (-1,98 %)     GBL 77.650 € (-0,26 %)     MELEXIS 74.650 € (-1,19 %)     TUBIZE-FIN 202.800 € (-1,55 %)     ONTEX GROUP 2.150 € (-0,92 %)     PROXIMUS 6.215 € (+0,40 %)     KINEPOLIS GROUP 37.050 € (-0,13 %)     NYXOAH 1.456 € (-2,41 %)     EVS 27.100 € (-0,18 %)     CELYAD ONCOLOGY 0.252 € (+2,44 %)     AGFA-GEVAERT 0.412 € (-0,60 %)     SHURGARD 25.750 € (-0,96 %)     QUESTFOR GR-PRICAF 2.910 € (-0,55 %)     CMB.TECH 13.660 € (+0,29 %)     IBA 17.140 € (0,00 %)     SOLVAC NOM(RETAIL) 75.000 € (+0,67 %)     CIE BOIS SAUVAGE 305.000 € (+0,66 %)     CENERGY 21.200 € (-1,40 %)     RECTICEL 11.800 € (+0,17 %)     BREDERODE 103.400 € (+0,19 %)     JENSEN-GROUP 80.600 € (-0,74 %)     DECEUNINCK 2.210 € (-0,45 %)     VIOHALCO 18.000 € (+1,47 %)     DEME GROUP 168.000 € (0,00 %)     EXMAR 11.300 € (0,00 %)     EKOPAK 3.580 € (-3,24 %)     BANQUP GROUP 2.110 € (-0,94 %)     HOME INVEST BE. 18.980 € (0,00 %)     BEKAERT 40.750 € (+0,62 %)     BQUE NAT. BELGIQUE 356.000 € (0,00 %)  
   HAVAS 18.450 € (0,00 %)     VIRIDIEN 81.300 € (-0,18 %)     STIF 52.850 € (-1,03 %)     CVC CAPITAL 13.550 € (-0,29 %)     VINCI 118.300 € (-0,88 %)     MAUNA KEA TECH 0.161 € (-1,23 %)     TOTALENERGIES 71.745 € (+1,88 %)     AMUNDI 87.850 € (-0,40 %)     SAINT GOBAIN 73.900 € (-1,31 %)     BNP PARIBAS ACT.A 100.240 € (-0,67 %)     ASM INTERNATIONAL 888.000 € (-0,18 %)     SCHNEIDER ELECTRIC 266.800 € (-0,65 %)     ASML HOLDING 1 539.200 € (-0,10 %)     SAFRAN 322.600 € (-2,27 %)     GENFIT 13.200 € (-2,22 %)     AEGON 7.685 € (-0,17 %)     AXA 44.070 € (-0,56 %)     SANOFI 76.140 € (-1,25 %)     AIR FRANCE -KLM 12.515 € (-2,91 %)     ARCELORMITTAL SA 58.620 € (+1,00 %)     ADYEN 823.700 € (-2,37 %)     ESSILORLUXOTTICA 163.850 € (-3,28 %)     AIRBUS 192.460 € (-1,44 %)     LVMH 476.600 € (-3,03 %)     CREDIT AGRICOLE 17.500 € (-0,28 %)     AIR LIQUIDE 176.420 € (-0,18 %)     SHELL PLC 37.070 € (+1,55 %)     COVIVIO 52.500 € (-1,69 %)     TEIXEIRA DUARTE 0.483 € (-0,92 %)     L'OREAL 375.400 € (-1,68 %)     AMOEBA 0.724 € (-1,90 %)     SOCIETE GENERALE 73.310 € (-1,78 %)     ASR NEDERLAND 67.700 € (-0,27 %)     NN GROUP 76.220 € (+0,16 %)     SWORD GROUP 30.200 € (-0,17 %)     KALRAY 8.110 € (-0,12 %)     AKZO NOBEL 56.940 € (-0,94 %)     AALBERTS NV 39.460 € (-0,35 %)     PERNOD RICARD 63.140 € (-1,68 %)     ARCHOS 0.219 € (-0,45 %)     CROSSJECT 1.660 € (-1,54 %)     LHYFE 2.780 € (+11,20 %)     UMG 18.280 € (-4,49 %)     AHOLD DEL 35.650 € (+0,14 %)     UBISOFT ENTERTAIN 5.514 € (-6,13 %)     PROSUS 38.750 € (-1,86 %)     IMCD 90.400 € (+4,87 %)     BAIKOWSKI 25.000 € (0,00 %)     STMICROELECTRONICS 61.410 € (-0,24 %)     FUGRO 9.455 € (-0,63 %)     ID LOGISTICS GROUP 341.000 € (-0,73 %)     DSM FIRMENICH AG 83.480 € (-0,41 %)     BAM GROEP KON 11.390 € (-1,47 %)     2CRSI 27.700 € (-6,10 %)     HEIJMANS KON 95.250 € (-1,70 %)     CASINO GUICHARD 0.183 € (-2,56 %)     CAPGEMINI 90.840 € (-0,85 %)     KERING 242.650 € (-3,08 %)     EDENRED 24.630 € (+0,20 %)     THALES 217.500 € (-1,63 %)  
News Réglementées
26/04/2023 15:00

FutureRx Expands the FRx Marketplace with Pharmacy and Medical Rebate Management Solutions from Nuwae

TAMPA, FL and COLLINSVILLE, CT / ACCESSWIRE / April 26, 2023 / FutureRx (FRx) and Nuwae, a member of the Goodroot community of companies, announced today the addition of Nuwae's pharmacy and medical rebate services and software to the FutureRx Marketplace, providing FRx health plan and pharmacy benefits manager (PBM) customers with streamlined access to rebate optimization and management solutions. With Nuwae on the FRx Marketplace, FRx customers can easily integrate solutions designed to lower prescription drug costs for both patients and payers from a company focused on solving the issues that drive medication prices to astronomical levels - thereby lowering out-of-pocket costs and providing equitable access and outcomes for stakeholders.

The FRx Marketplace is part of the innovative FRx cloud-based healthcare platform, which brings to market a unique combination of modular technology solutions and a comprehensive network of pre-vetted, fully integrated service providers delivering a full range of specialized services. These services include, but are not limited to, customer service, formulary and rebate management, prior authorization, appeals and grievance management, mobile low-cost drug alternatives, and more. FRx Marketplace service partners - now including Nuwae as well as mFax, Surescripts and many others - are fully integrated with FRx technology modules for rapid go-to-market and hassle-free service changes. FRx customers can also utilize their excess capacity or specialized skill sets to sell their services on the FRx Marketplace.

Nuwae partners with PBMs and health plans to uncover new possibilities for growth through competitive rebates and innovative solutions that help position them for market success and provide greater value across the board for its partners and their clients and members. It will offer two solutions on the FRx Marketplace:

  • Pharmacy Rebates: End-to-end rebate management services, clinically driven formularies, clinical expertise, and purpose-built rebate processing software that provides claim-level reporting. It cuts through the complexities of the pharmacy rebate landscape with ease and maximizes savings for PBMs, health plans, and their clients and members.
  • Medical Rebates: Simplifies and increases the value of the rebate process for health plans by securing and managing rebates that are often overlooked or missing.

"Nuwae's focus on reinventing patient drug access and affordability through pharmacy and medical rebates, as well as new innovative drug pricing solutions, makes it the ideal complement to the FRx Marketplace," said Mark Francen, Chief Product Officer, FutureRx. "The synergy between the two companies will help FRx advance our mission to put control back into the hands of health plans and PBMs, in part by eliminating the complicated process of vetting, contracting, and managing critical outsourced service relationships."

Adds Michelle Frank, Chief Growth Officer, Goodroot: "The easy access to innovative solutions FutureRx has created through their FRx Marketplace is the perfect solution to help Nuwae achieve our mission of reinventing patient drug access and affordability. Through this partnership, we are able to reach more PBMs and health plans with our solutions, which we believe can have significant impact on driving down prescription costs for patients."

Follow FutureRx on LinkedIn, Twitter, and Facebook.

About FutureRx

FutureRx (FRx) offers a first-of-its-kind healthcare platform for health plans and pharmacy benefits managers (PBMs) that combines technology and access to pre-vetted fully integrated service providers on a single platform. FRx is a cloud-based, modular, user-configurable technology solution that was built from the ground up to meet complex and continuously evolving compliance requirements in today's Medicare and Medicaid environment. The FRx Marketplace provides access to a comprehensive network of pre-vetted partners delivering a full range of specialized technologies and services including drug management, formulary and rebate management, prior authorization, appeals and grievance management, mobile low-cost drug alternatives, and more. FRx Marketplace service partners are fully integrated with FRx technology solutions for rapid go-to-market and hassle-free service changes. FRx customers can also gain a new revenue stream by selling their services on the FRx Marketplace. For more information, visit https://futurerx.com/.

About Goodroot

Goodroot is a community of companies reinventing healthcare one system at a time. With a shared mission of increasing affordability and access in healthcare, Goodroot provides business infrastructure to help visionary healthcare professionals launch their own companies to fix chronic problems in the system. Goodroot's affiliate companies - AlignRx, Breez, CoeoRx, Emry Health, Nuwae, Penstock, RemedyOne and Sola - offer innovative services and strategic guidance for healthcare stakeholders such as employers, brokers, PBMs, health plans, third-party administrators, pharmaceutical manufacturers and hospitals. Goodroot was named a 2023 Top Impact Company by Real Leaders. goodrootinc.com.

Media Contacts:

FutureRx
Liz Goar, NPC Creative Services
liz@npccs.com

Nuwae
Liz Chasse, Goodroot
lchasse@goodrootinc.com

# # #

SOURCE: FutureRx



View source version on accesswire.com:
https://www.accesswire.com/751138/FutureRx-Expands-the-FRx-Marketplace-with-Pharmacy-and-Medical-Rebate-Management-Solutions-from-Nuwae

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière